Acutus Medical to Announce First Quarter 2022 Financial Results

Rhea-AI Summary

Acutus Medical, Inc. (Nasdaq: AFIB) will announce its first quarter 2022 financial results on May 12, 2022, and will conduct a conference call at 1:30 p.m. PT to discuss these results. The call will also cover recent highlights in the company's approach to diagnosing and treating cardiac arrhythmias. Interested parties can participate via telephone or by accessing the live webinar on their investor relations website. Acutus focuses on advancing electrophysiology with a range of differentiated products aimed at enhancing treatment efficiency for arrhythmias.

CARLSBAD, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its first quarter 2022 financial results on Thursday, May 12, 2022. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (833) 570-1131 for domestic callers or (914) 987-7078 for international callers, using conference ID: 3455233. The live webinar of the call may be accessed by visiting the Events section of the Acutus investor relations website at ir.acutusmedical.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company’s website.

About Acutus Medical, Inc.
Acutus is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

Investor Contact:
Caroline Corner
ICR Westwicke
D: 415-202-5678
caroline.corner@westwicke.com

Holly Windler
M: 619-929-1275
media@acutusmedical.com

 

FAQ

When will Acutus Medical announce its Q1 2022 financial results?

Acutus Medical will announce its Q1 2022 financial results on May 12, 2022.

What time is the Acutus Medical conference call for Q1 2022 results?

The conference call for Acutus Medical's Q1 2022 results is scheduled for 1:30 p.m. Pacific Time.

How can I access the Acutus Medical conference call for Q1 2022?

You can access the conference call by dialing (833) 570-1131 domestically or (914) 987-7078 internationally, using conference ID: 3455233.

Where can I find the replay of the Acutus Medical Q1 2022 webcast?

The replay of the Acutus Medical Q1 2022 webcast will be available on the company's investor relations website shortly after the call concludes.

What is Acutus Medical's focus in the healthcare industry?

Acutus Medical focuses on improving the diagnosis and treatment of cardiac arrhythmias through innovative electrophysiology products and technologies.